Lifecore Biomedical
LFCR
LFCR
105 hedge funds and large institutions have $112M invested in Lifecore Biomedical in 2026 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 30 increasing their positions, 33 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
9% less repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 33
50% less capital invested
Capital invested by funds: $226M → $112M (-$114M)
Holders
105
Holding in Top 10
5
Calls
$198K
Puts
$165K
Top Buyers
| 1 | +$1.93M | |
| 2 | +$1.46M | |
| 3 | +$656K | |
| 4 |
GC
Grizzlyrock Capital
Chicago,
Illinois
|
+$582K |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$519K |
Top Sellers
| 1 | -$1M | |
| 2 | -$977K | |
| 3 | -$653K | |
| 4 |
PFCS
Pale Fire Capital SE
Prague,
Czech Republic
|
-$581K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$408K |
